Greg Whitehead

Greg Whitehead has a diverse work experience spanning over several industries. Greg is currently serving as the Senior Vice President, Quality at Editas Medicine since October 2022. Prior to this, Greg was on sabbatical at Whitehead Homestead in October 2022. Before that, they held the position of Senior Vice President and Chief Quality Officer at Rubius Therapeutics from March 2019 to September 2022. Greg has also worked at bluebird bio as the Vice President, Quality from March 2017 to March 2019, and as the Sr. Director, QA from December 2014 to February 2017. Greg'searlier roles include positions at Dendreon as the Director, Corporate Quality Assurance from July 2010 to November 2014, Acting Director, Quality Assurance from January 2010 to July 2010, and Senior Manager, Quality Assurance from February 2009 to July 2010. Greg also served as the Senior Manager, Quality Control at Dendreon from September 2004 to February 2009. Greg's earlier experience includes working as the Supervisor of Biochemistry at Emergent BioSolutions from July 1999 to September 2004, and as a Medical Technologist - Toxicology at Sparrow Health System from July 1993 to July 1999.

Greg Whitehead obtained their Bachelor's degree in Forensic Science from Michigan State University, completing their education in the year 1991.